Based on the homing and penetrating peptides of breast tumor, a peptide assembling nano-delivery system was developed to deliver siPD-L1 and indoleamine 2,3-dioxygenase inhibitor in order to activate cytotoxic CD8+ T cells, and ultimately enhanced ICI-induced apoptosis of breast cancer cells [291]. This evidence concerns the gene IDO2 and breast carcinoma.